Clinical study to evaluate safety and efficacy of tacrolimus 0.1% eye ointment in treatment of vernal keratoconjunctivitis
Journal Title: Indian Journal of Clinical and Experimental Ophthalmology - Year 2017, Vol 3, Issue 4
Abstract
Introduction: Vernal keratoconjunctivitis is a seasonally recurring, chronic, allergic bilateral inflammatory disorder of the conjunctiva and cornea caused due to immune mediated hypersensitivity reaction. Tacrolimus is an immunomodulator which induces suppression of T lymphocytes activity and causes reduction of ocular inflammation. Hence, in our present study we aim to evaluate the efficacy of 0.1% tacrolimus eye ointment as first line therapy in the management of Vernal Keratoconjunctivitis. Materials and Methods: This was a clinical, prospective and interventional study including 100 eyes of 50 patients with VKC which were serially selected. 0.1% tacrolimus eye ointment was instilled twice daily over a period of 12 weeks. On every fortnightly follow up, patients were assessed for 5 symptoms and 4 signs and the severity was graded as 0 (normal), 1+ (mild), 2+ (moderate), or 3+ (severe)in order to evaluate the efficacy of the drug. Results: There were 50 patients with VKC comprising of 41 males and 09 females. After treatment with Tacrolimus 0.1% eye ointment, there was statistically significant improvement in symptoms of VKC including itching, redness, photosensitivity, foreign body sensation and mucus discharge (P<0.001). Significant improvement in clinical signs of VKC including conjunctival hyperaemia, papillary hypertrophy, giant papillary conjunctivitis and limbal involvement (P<0.001) was seen at the end of the study. No significant adverse effects of tacrolimus were seen in these patients. Conclusion: Topical 0.1% tacrolimus eye ointment is very effective in the treatment of Vernal Keratoconjunctivitis with minimal long term side effects.
Authors and Affiliations
Rajni Sethi, R N Kothari, Vivan Desai, Aditya Desai, Anjasi Patel
An overview of complications of MSICS
Introduction Taking into consideration the wide spectrum of complications that follow MSICS and their influence on visual outcome a sincere effort has been made in this study to critically analyze the incidence and the n...
Efficacy and safety of subconjuctival bevacizumab injection in the management of pterygium
Purpose To assess the efficacy and safety of subconjunctival bevacizumab in the management of grade II and III pterygiumMaterials and Methods Cases of pterygium with no other ocular abnormality and with no systemic disor...
A study of ocular sarcoidosis using international workshop for ocular sarcoidosis criteria in a south Indian population
Purpose To study the clinical profile of patients with ocular sarcoidosis using the new International Workshop for Ocular Sarcoidosis IWOS guidelines in a tertiary care hospital in South IndiaMaterials and Methods A retr...
The clinical and etiological study of the Oculomotor nerve palsy in a rural hospital
Background: Most of the times the oculomotor palsies are referred to an ophthalmologist from various other specialities, as they are often perceived as a sign of serious underlying pathology, like a compression of the oc...
Correlation study of modifiable risk factors and age related Maculopathy
Aim and Objective: To study relationship between ARMD and risk factors. Methodology: A total sample size of 4000 patients above 60 years attending ophthalmology OPD of center were enrolled in the study. The data collecti...